Prediction of Thrombosis Risk in Atopic Dermatitis Patients Treated with JAK Inhibitors: Development of the Thrombo-JAK score
We developed and validated the Thrombo-JAK score, a machine-learning–derived thrombosis risk model for adults with atopic dermatitis treated with JAK1-selective inhibitors. Among 305 patients, the model demonstrated good discrimination (AUC 0.72) and identified clinically meaningful laboratory thresholds that stratified thrombosis risk from 3.4% to 31.0% across score categories. This simple, interpretable tool may support individualized risk assessment and safer prescribing of JAK inhibitors in dermatologic practice.
Authors
- Danielle Bar (ORCID: https://orcid.org/0009-0007-6057-7847)
- Ilia Berberashvili
Institutions
- Tel Aviv University (IL)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1093/bjd/ljag489
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00